Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer

Go back to Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer
(NASDAQ: COLL) Delayed: 22.11 --0 (-0%)
Previous Close $22.11    52 Week High $30.58 
Open $22.11    52 Week Low $8.24 
Day High $22.11    P/E N/A 
Day Low $22.11    EPS $0.00 
Volume 2,315